Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
QHSLab Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE
Ticker
Exchange
SIC #
Website
Latest Ticker
USAQ
Over the counter
8011
http://www.mabxa.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for QHSLab Inc
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
- Jan 30th, 2023 1:30 pm
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
- Nov 14th, 2022 1:30 pm
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force
- Nov 1st, 2022 12:30 pm
QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
- Sep 20th, 2022 12:30 pm
QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
- Jun 24th, 2022 12:30 pm
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
- May 24th, 2022 12:00 pm
New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT™.
- May 10th, 2022 12:30 pm
QHSLab. Issues Update and Investor Presentation May 2022
- May 9th, 2022 12:30 pm
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
- Apr 19th, 2022 12:30 pm
USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
- Apr 5th, 2022 12:00 pm
QHSLab Expands Digital Prescription Product Portfolio in 2022
- Feb 16th, 2022 1:00 pm
Scroll